Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 3
2005 4
2006 6
2007 7
2008 9
2009 10
2010 5
2011 9
2012 10
2013 11
2014 10
2015 7
2016 6
2017 6
2018 10
2019 6
2020 8
2021 8
2022 7
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS. Normanno N, et al. Among authors: de luca a. Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27. Gene. 2006. PMID: 16377102 Review.
IL-22 in antifungal immunity.
Zelante T, Iannitti R, De Luca A, Romani L. Zelante T, et al. Among authors: de luca a. Eur J Immunol. 2011 Feb;41(2):270-5. doi: 10.1002/eji.201041246. Epub 2011 Jan 11. Eur J Immunol. 2011. PMID: 21267995 Free article. Review.
Optimizing the Choice for Adjuvant Chemotherapy in Gastric Cancer.
Grassadonia A, De Luca A, Carletti E, Vici P, Di Lisa FS, Filomeno L, Cicero G, De Lellis L, Veschi S, Florio R, Brocco D, Alberti S, Cama A, Tinari N. Grassadonia A, et al. Among authors: de luca a. Cancers (Basel). 2022 Sep 25;14(19):4670. doi: 10.3390/cancers14194670. Cancers (Basel). 2022. PMID: 36230592 Free PMC article. Review.
Pharmacokinetic evaluation of zoledronic acid.
De Luca A, Lamura L, Gallo M, Daniele G, D'Alessio A, Giordano P, Maiello MR, Pergameno M, Perrone F, Normanno N. De Luca A, et al. Expert Opin Drug Metab Toxicol. 2011 Jul;7(7):911-8. doi: 10.1517/17425255.2011.585156. Epub 2011 May 13. Expert Opin Drug Metab Toxicol. 2011. PMID: 21563999 Review.
Thymosin alpha1: the regulator of regulators?
Pierluigi B, D'Angelo C, Fallarino F, Moretti S, Zelante T, Bozza S, De Luca A, Bistoni F, Garaci E, Romani L. Pierluigi B, et al. Among authors: de luca a. Ann N Y Acad Sci. 2010 Apr;1194:1-5. doi: 10.1111/j.1749-6632.2010.05465.x. Ann N Y Acad Sci. 2010. PMID: 20536444 Review.
VEGF as a potential target in lung cancer.
Frezzetti D, Gallo M, Maiello MR, D'Alessio A, Esposito C, Chicchinelli N, Normanno N, De Luca A. Frezzetti D, et al. Among authors: de luca a. Expert Opin Ther Targets. 2017 Oct;21(10):959-966. doi: 10.1080/14728222.2017.1371137. Epub 2017 Aug 30. Expert Opin Ther Targets. 2017. PMID: 28831824 Review.
FGFR-targeted therapeutics for the treatment of breast cancer.
De Luca A, Frezzetti D, Gallo M, Normanno N. De Luca A, et al. Expert Opin Investig Drugs. 2017 Mar;26(3):303-311. doi: 10.1080/13543784.2017.1287173. Epub 2017 Feb 6. Expert Opin Investig Drugs. 2017. PMID: 28121208 Review.
Bridging therapeutic opportunities: a survey by the Italian molecular tumor board workgroup of Alliance Against Cancer.
Ciliberto G, Canfora M, Terrenato I, Agnoletto C, Agustoni F, Amoroso L, Baldassarre G, Curigliano G, Delmonte A, De Luca A, Fiorentino M, Gregorc V, Ibrahim T, Lazzari C, Mastronuzzi A, Pronzato P, Santoro A, Scambia G, Tommasi S, Vingiani A, Giacomini P, De Maria R. Ciliberto G, et al. Among authors: de luca a. J Exp Clin Cancer Res. 2022 Oct 17;41(1):305. doi: 10.1186/s13046-022-02512-0. J Exp Clin Cancer Res. 2022. PMID: 36245005 Free PMC article.
141 results